Heart care quality program for AFib and heart failure
Part of Heart & circulation clinical trials.
This trial aims to improve care for people with atrial fibrillation (a type of irregular heartbeat) or heart failure with reduced pumping strength. It focuses on making sure you get the right treatments based on your health history and recent visits to a heart doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an active diagnosis of atrial fibrillation (a type of irregular heartbeat) or heart failure with reduced pumping strength (EF ≤ 40%)
- Your CHADS2VASC score (a measure of stroke risk) is at least 2 for men or at least 3 for women (for AFib group)
- You had a visit with a heart doctor in the past 3 months
- You are between 18 and 90 years old (for heart failure group)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This study looks at patients who have both atrial fibrillation (irregular heartbeats) and heart failure. It aims to predict health outcomes for people who are having a procedure called ablation, which aims to restore a normal heart rhythm. Participating could help doctors understand who might benefit most from this treatment.
This study tests whether a procedure called catheter ablation, which treats irregular heartbeats in atrial fibrillation, can improve outcomes in people who also have heart failure with mildly reduced or preserved pumping function. The procedure aims to restore a normal heart rhythm and may help reduce symptoms.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.